| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | A3M1353L40 |
| InChI Key | BJDZBXGJNBMCAV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H23F3N4O3S |
| Molecular Weight | 456.49 |
| AlogP | 4.29 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 79.58 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 31.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 3770 | - | - | - | |
|
Enzyme
Oxidoreductase
|
- | 10 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 41-42 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Tuberculosis | 2 | D014376 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3330226 |
| DrugBank | DB14821 |
| FDA SRS | A3M1353L40 |
| PubChem | 57331386 |
| SureChEMBL | SCHEMBL6128230 |
| ZINC | ZINC000141433347 |